by Alex Lennox-Miller | January 30, 2020
Guidance on Clinical Decision Support: Definitions and Transparency
Roughly two years after we reviewed the first FDA guidance on Clinical Decision Support (CDS), FDA issued new draft guidance. […]
Tag Archive: FDA
by Alex Lennox-Miller | January 30, 2020
Roughly two years after we reviewed the first FDA guidance on Clinical Decision Support (CDS), FDA issued new draft guidance. […]
by Chilmark Team | December 10, 2018
The Meaningful Use gravy train finally came to an end in 2018. As the strongest EHR vendors struggle to define […]
by Chilmark Team | November 29, 2018
As is our custom here, we like to look back on our predictions for the closing year and see just […]
by Brian Edwards | December 19, 2017
Key Takeaways: The FDA has released long-anticipated draft guidance on how they intend to regulate clinical decision support products. For […]
by Naveen Rao | July 27, 2015
Progress? Healthcare organizations (HCOs) are acknowledging the need for next generation tools to realize the promise of newer models of […]
by Naveen Rao | March 28, 2015
A Worthy Read This month’s Domain Monitor is a little bit different. We recently read through Dr. Eric Topol’s latest […]
by John Moore lll | November 27, 2013
As most of our readers are likely aware, the FDA this week issued a scathing letter effectively prohibiting the 5 […]
by John Moore | April 04, 2013
We came back from HIMSS and got right to work on the March Monthly Update for Chilmark Advisory Services subscribers. As […]
John Moore III · 3 weeks ago
John Moore III · 4 weeks ago